The London-Laurel County Chamber of Commerce opened its first luncheon of 2026 with reflections from outgoing leadership, new ...

Under the terms of the agreement, Pfizer is expected to pay an upfront total of $30 million in early 2026 to Novavax, while ...

GSK and Shionogi have agreed with Pfizer to restructure ViiV Healthcare’s shareholder base, with Shionogi replacing Pfizer’s 11.7 percent economic interest and increasing its stake to 21.7 percent, ...

Around 80 residents attended the Normal Firefighters International Association of Firefighters Local 2442 town hall on its ...

Autobahn Therapeutics, a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders, today announced the presentation of new ...

BioNTech (NASDAQ:BNTX) used a presentation and question-and-answer session at the J.P. Morgan Healthcare Conference to ...

Pfizer is gearing up for a consumer-driven obesity drug market, drawing parallels to the demand surge it experienced with the launch of Viagra (sildenafil), CEO Albert Bourla said at the 44th Annual ...

Tempus AI (NASDAQ:TEM) shares rose about 10% on Monday after the company filed preliminary, unaudited results showing roughly $1.27 billion in 2025 revenue. The filing shows full-year revenue up about ...

Mattel says it developed the new Barbie in partnership with a nonprofit organization that advocates for the rights and better ...

Colorectal cancer is the third most common cancer globally, with approximately 1.8 million people diagnosed in 2022 ...

Madrigal Pharma is reheating a drug for metabolic dysfunction-associated steatohepatitis (MASH) put on ice by Pfizer, hoping to build on its first-mover advantage in therapies for the widespread liver ...

American pharma giant Pfizer (PFE) leads the pack as pharmaceutical companies plan price increases for at least 350 branded medications, according to data seen by Reuters. The move underscores the ...